PD-L1 expression is considered to play a role in the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, which promotes the glucose metabolism of the tumor through the synthesis of glycolytic enzymes [21]. This evidence concerns the gene AKT1 and neoplasm.